Posted on 1/25/21
Is CVS Health a Great Dividend Stock?
CVS Health (NYSE:CVS) is the nation's largest chain pharmacy retailer, with control of nearly 25% of the market. It also has the reputation as a solid . . .
Posted on 1/25/21
Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg
Investors have been excited for quite a while now about Moderna's (NASDAQ:MRNA) COVID-19 vaccine, mRNA-1273. And for good reason. Moderna stands to make billions of dollars . . .
Posted on 1/25/21
Could Moderna Be a Millionaire-Maker Stock?
If you had bought shares of Moderna (NASDAQ:MRNA) in January 2020, you would be sitting pretty right now. Thanks to its coronavirus-related efforts, shares of the . . .
Posted on 1/25/21
What Are Moderna's Risks?
Moderna (NASDAQ:MRNA) is a high-flying biotech stock with a big year ahead of it. The company should make billions of dollars in 2021 from sales of . . .
Posted on 1/25/21
Fulcrum Therapeutics Closes Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically . . .
Posted on 1/25/21
Average Positive Test Rate is Slightly Higher for Older Marylanders than Younger Marylanders for First Time Since May
For the first time since May, the seven-day average rate of positive coronavirus tests is slightly higher for older Marylanders than for younger Marylanders.Of the coronavirus . . .
Posted on 1/22/21
Precigen Prices of $112.5 Million Public Offering of Common Stock
Precigen, Inc. (Nasdaq: PGEN) today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of . . .
Posted on 1/22/21
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug . . .
Posted on 1/22/21
$125M Pharma Manufacturing Plant Coming to Petersburg
Utah-based pharmaceutical manufacturer Civica Inc. plans to invest $124.5 million to establish its North American manufacturing headquarters operation in Petersburg, creating 186 jobs and manufacturing injectable . . .
Posted on 1/22/21
Better Coronavirus Stock: Novavax or Vaxart?
Both Moderna and Pfizer have brought coronavirus vaccines to market, but there still are plenty of opportunities to bet on players that haven't yet brought their . . .
Posted on 1/22/21
3 Reasons to Buy Novavax Stock, and 1 Reason to Sell
Novavax (NASDAQ:NVAX) is nearing the finish line of the coronavirus vaccine race. The clinical-stage biotech company expects to report interim data from a phase 3 trial . . .
Posted on 1/22/21
Is Johnson & Johnson a Buy?
Johnson & Johnson (NYSE:JNJ) is a blue-chip pharma stock with annual revenues in the neighborhood of $80 billion -- and that's before considering the potential of . . .
Posted on 1/22/21
Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program
The distribution of coronavirus vaccines in lower-income countries could get a huge boost soon. On Thursday, two sources familiar with the matter told Reuters that Pfizer . . .
Posted on 1/22/21
Caladrius Biosciences Announces $25M Private Placement
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/22/21
Senseonics Holdings Announces $50M Bought Deal Offering of Common Stock
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) . . .
Posted on 1/22/21
Precigen Proposes Public Offering of Common Stock
Precigen, Inc. (Nasdaq: PGEN) today announced it has commenced an underwritten public offering of shares of its common stock. In addition, Precigen intends to grant the . . .
Posted on 1/22/21
NeuroBo Pharmaceuticals Closes $10.0 Million Private Placement
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the closing of its previously announced private placement of an aggregate 2,500,000 shares of its . . .
Posted on 1/22/21
Phio Pharmaceuticals Announces $14.0 Million Private Placement
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 1/22/21
Maryland Reports 2,166 New Coronavirus Cases, 46 COVID-19 Deaths
Maryland health officials on Thursday reported another 2,166 coronavirus cases and 46 new deaths related to the virus.At least 334,519 Marylanders have tested positive for COVID-19, . . .
Posted on 1/21/21
OncoSec Medical Prices of $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and to guide an . . .
Posted on 1/21/21
Synaptogenix Announces $14.0 Million Private Placement
Synaptogenix, Inc. (OTCQX: SNPX), formerly Neurotrope Bioscience, Inc., announced today that it has entered into definitive securities purchase agreements with accredited investors to raise approximately $14.0 million . . .
Posted on 1/21/21
Vestar Capital Partners Makes a Majority Investment in Dr. Praeger's Sensible Foods
Vestar Capital Partners, a leading U.S. middle-market private equity firm, announced today that it has made a majority growth investment into Dr. Praeger's Sensible Foods, a . . .
Posted on 1/21/21
Boston Scientific To Acquire Preventice Solutions
Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full . . .
Posted on 1/21/21
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
WINDSOR, Conn.--(BUSINESS WIRE)--SCA Pharmaceuticals, LLC, has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Partners.The Vistria Group and Excellere Partners have . . .
Posted on 1/21/21
Caladrius Biosciences Announces $25.0 Million Private Placement
BASKING RIDGE, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
